Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) Director Linda Marsh sold 250,000 shares of the firm’s stock in a transaction dated Friday, June 17th. The shares were sold at an average price of $37.00, for a total transaction of $9,250,000.00. Following the transaction, the director now directly owns 270,081 shares in the company, valued at approximately $9,992,997. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Shares of Apollo Medical stock opened at $34.73 on Friday. The firm’s 50 day moving average price is $36.88 and its 200-day moving average price is $49.97. The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.38. Apollo Medical Holdings, Inc. has a 52-week low of $29.52 and a 52-week high of $133.23. The company has a market cap of $1.95 billion, a P/E ratio of 21.31 and a beta of 0.56.
Apollo Medical (NASDAQ:AMEH – Get Rating) last issued its quarterly earnings data on Thursday, May 5th. The company reported $0.31 earnings per share (EPS) for the quarter. Apollo Medical had a net margin of 8.71% and a return on equity of 16.80%. The firm had revenue of $263.26 million for the quarter.
A number of research firms have commented on AMEH. TheStreet downgraded shares of Apollo Medical from a “b-” rating to a “c+” rating in a research report on Monday, March 7th. Colliers Securities reaffirmed a “buy” rating on shares of Apollo Medical in a research report on Tuesday, March 22nd.
Institutional investors have recently modified their holdings of the company. Captrust Financial Advisors grew its position in shares of Apollo Medical by 49.0% in the 3rd quarter. Captrust Financial Advisors now owns 359 shares of the company’s stock worth $33,000 after buying an additional 118 shares during the last quarter. Lindbrook Capital LLC boosted its stake in Apollo Medical by 3,938.9% in the 4th quarter. Lindbrook Capital LLC now owns 727 shares of the company’s stock worth $53,000 after purchasing an additional 709 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in Apollo Medical in the 1st quarter worth approximately $66,000. PNC Financial Services Group Inc. boosted its stake in Apollo Medical by 49.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock worth $75,000 after purchasing an additional 520 shares in the last quarter. Finally, MML Investors Services LLC acquired a new stake in Apollo Medical in the 3rd quarter worth approximately $212,000. 30.81% of the stock is currently owned by hedge funds and other institutional investors.
Apollo Medical Company Profile (Get Rating)
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
Receive News & Ratings for Apollo Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Apollo Medical and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
